Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Allergan Aesthetics invests in women’s career trajectories to close STEM gap
Medical Marketing and Media
Tue, 10/3/23 - 07:23 pm
Tags:
AbbVie, Allergan Aesthetics, women, STEM
Boehringer launches 81% discounted biosimilar of AbbVie's Humira
Reuters
Mon, 10/2/23 - 06:34 pm
Tags:
Boehringer Ingelheim, biosimilars, AbbVie, Humira, unbranded biosimilars
AbbVie’s venetoclax fails Phase III myeloma trial
Clinical Trials Arena
Mon, 10/2/23 - 10:12 am
Tags:
AbbVie, venetoclax, Multiple Myeloma, clinical trials
Top Pharma Ad Spenders in August 2023, AbbVie Splurges to Take Top Spots
Xtalks
Sun, 10/1/23 - 01:28 pm
Tags:
pharma advertising, DTC ads, AbbVie, Skyrizi, Rinvoq, Regeneron
In label expansion bid, AbbVie and Roche's Venclexta falls short in multiple myeloma subset
Fierce Pharma
Fri, 09/29/23 - 12:13 pm
Tags:
AbbVie, Roche, Venclexta, Multiple Myeloma
AbbVie Terminates Collaboration and License Agreement with Caribou Biosciences
Best Stocks
Tue, 09/26/23 - 10:12 pm
Tags:
AbbVie, Caribou Biosciences, CRISPR
AbbVie Ends I-Mab Partnership for CD47 Antibody Compounds, Products
BioSpace
Mon, 09/25/23 - 10:04 am
Tags:
AbbVie, I-Mab Biopharma
Third Time Might Be a Charm for Alvotech as FDA Accepts BLA for Humira Biosimilar
BioSpace
Thu, 09/21/23 - 11:53 am
Tags:
Alvotech, FDA, biosimilars, AVT02, AbbVie, Humira
Revance rolls out a price drop for Daxxify as it tries to challenge AbbVie's Botox
Fierce Pharma
Wed, 09/20/23 - 08:57 am
Tags:
Revance Therapeutics, Daxxify, AbbVie, Botox, drug pricing
With trial win, AbbVie cues up Botox for another cosmetic indication
Fierce Pharma
Mon, 09/18/23 - 07:47 pm
Tags:
AbbVie, Botox, aesthetics, platysma prominence
AbbVie Passes on License Option for Harpoon’s TriTAC Multiple Myeloma Program
BioSpace
Thu, 09/14/23 - 10:02 am
Tags:
AbbVie, Harpoon Therapeutics, HPN217, Multiple Myeloma
AbbVie’s Skyrizi Outperforms J&J’s Stelara in Late-Stage Crohn’s Disease Trial
BioSpace
Wed, 09/13/23 - 11:36 am
Tags:
AbbVie, Skyrizi, JNJ, Stelara, Crohn's Disease, clinical trials
GSK spends big on new RSV vax commercials, but it's an AbbVie clean sweep as August's top pharma drug ad spender
Fierce Pharma
Sun, 09/10/23 - 07:58 pm
Tags:
AbbVie, GSK, DTC advertising, pharma marketing
AbbVie’s Humira to Take Hit from Biosimilars, Next-Gen Therapies: Report
BioSpace
Fri, 09/8/23 - 11:29 am
Tags:
AbbVie, Humira, biosimilars, Crohn's Disease
AbbVie in line for hefty payout after Takeda breached supply contract on Lupron
Fierce Pharma
Thu, 09/7/23 - 10:25 am
Tags:
AbbVie, Takeda, legal, Lupron
Biden administration lists 10 drugs for Medicare price negotiation
Medical Marketing and Media
Tue, 08/29/23 - 11:43 am
Tags:
Medicare, HHS, Pfizer, Bristol Myers Squibb, Eli Lilly, Boehringer Ingelheim, AstraZeneca, AbbVie, Novo Nordisk, JNJ, drug pricing
AbbVie Removes Two Early-Stage Cancer Assets from Pipeline
BioSpace
Thu, 08/24/23 - 11:44 am
Tags:
AbbVie, antibody-drug conjugate, cancer
Why AbbVie’s former president has high hopes for this Flagship-backed biotech
Pharma Voice
Tue, 08/8/23 - 10:29 am
Tags:
Tessara Therapeutics, gene writing, AbbVie, Flagship Pioneering, Michael Severino
Amgen's hyped Humira biosimilar fritters away its exclusivity advantage
Fierce Pharma
Fri, 08/4/23 - 11:56 am
Tags:
Amgen, AbbVie, biosimilars, Humira
Despite big Q2 declines for Humira and Imbruvica, AbbVie still boosts earnings guidance
Fierce Pharma
Thu, 07/27/23 - 11:37 pm
Tags:
AbbVie, earnings, Humira, biosimilars, Imbruvica

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.